Inactivation of specific β cell transcription factors in type 2 diabetes
- PMID: 23863625
- PMCID: PMC3726150
- DOI: 10.1172/JCI65390
Inactivation of specific β cell transcription factors in type 2 diabetes
Abstract
Type 2 diabetes (T2DM) commonly arises from islet β cell failure and insulin resistance. Here, we examined the sensitivity of key islet-enriched transcription factors to oxidative stress, a condition associated with β cell dysfunction in both type 1 diabetes (T1DM) and T2DM. Hydrogen peroxide treatment of β cell lines induced cytoplasmic translocation of MAFA and NKX6.1. In parallel, the ability of nuclear PDX1 to bind endogenous target gene promoters was also dramatically reduced, whereas the activity of other key β cell transcriptional regulators was unaffected. MAFA levels were reduced, followed by a reduction in NKX6.1 upon development of hyperglycemia in db/db mice, a T2DM model. Transgenic expression of the glutathione peroxidase-1 antioxidant enzyme (GPX1) in db/db islet β cells restored nuclear MAFA, nuclear NKX6.1, and β cell function in vivo. Notably, the selective decrease in MAFA, NKX6.1, and PDX1 expression was found in human T2DM islets. MAFB, a MAFA-related transcription factor expressed in human β cells, was also severely compromised. We propose that MAFA, MAFB, NKX6.1, and PDX1 activity provides a gauge of islet β cell function, with loss of MAFA (and/or MAFB) representing an early indicator of β cell inactivity and the subsequent deficit of more impactful NKX6.1 (and/or PDX1) resulting in overt dysfunction associated with T2DM.
Figures









Similar articles
-
The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity.Cell Death Dis. 2018 Feb 15;9(3):279. doi: 10.1038/s41419-018-0272-z. Cell Death Dis. 2018. PMID: 29449530 Free PMC article.
-
Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.PLoS One. 2018 May 3;13(5):e0196570. doi: 10.1371/journal.pone.0196570. eCollection 2018. PLoS One. 2018. PMID: 29723228 Free PMC article.
-
Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo.J Biol Chem. 2015 Mar 20;290(12):7647-57. doi: 10.1074/jbc.M114.595579. Epub 2015 Feb 2. J Biol Chem. 2015. PMID: 25645923 Free PMC article.
-
Role of the Transcription Factor MAFA in the Maintenance of Pancreatic β-Cells.Int J Mol Sci. 2022 Apr 19;23(9):4478. doi: 10.3390/ijms23094478. Int J Mol Sci. 2022. PMID: 35562869 Free PMC article. Review.
-
Roles and regulation of transcription factor MafA in islet beta-cells.Endocr J. 2007 Dec;54(5):659-66. doi: 10.1507/endocrj.kr-101. Epub 2007 Aug 30. Endocr J. 2007. PMID: 17785922 Review.
Cited by
-
Transcriptional mechanisms of pancreatic β-cell maturation and functional adaptation.Trends Endocrinol Metab. 2021 Jul;32(7):474-487. doi: 10.1016/j.tem.2021.04.011. Epub 2021 May 21. Trends Endocrinol Metab. 2021. PMID: 34030925 Free PMC article. Review.
-
The Plasticity of Pancreatic β-Cells.Metabolites. 2021 Apr 2;11(4):218. doi: 10.3390/metabo11040218. Metabolites. 2021. PMID: 33918379 Free PMC article. Review.
-
Redox Homeostasis in Pancreatic β-Cells: From Development to Failure.Antioxidants (Basel). 2021 Mar 27;10(4):526. doi: 10.3390/antiox10040526. Antioxidants (Basel). 2021. PMID: 33801681 Free PMC article. Review.
-
Administration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male Rats.Endocrinology. 2016 Dec;157(12):4720-4731. doi: 10.1210/en.2016-1309. Epub 2016 Sep 21. Endocrinology. 2016. PMID: 27653034 Free PMC article.
-
β-Cell Heterogeneity and Plasticity.Adv Anat Embryol Cell Biol. 2024;239:57-90. doi: 10.1007/978-3-031-62232-8_3. Adv Anat Embryol Cell Biol. 2024. PMID: 39283482 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- R56 DK050203/DK/NIDDK NIH HHS/United States
- R01 DK038325/DK/NIDDK NIH HHS/United States
- DK068471/DK/NIDDK NIH HHS/United States
- R56 DK038325/DK/NIDDK NIH HHS/United States
- P30 HD015052/HD/NICHD NIH HHS/United States
- U01 DK072473/DK/NIDDK NIH HHS/United States
- DK66636/DK/NIDDK NIH HHS/United States
- P30 EY008126/EY/NEI NIH HHS/United States
- R33 DK066636/DK/NIDDK NIH HHS/United States
- DK89572/DK/NIDDK NIH HHS/United States
- R01 DK069603/DK/NIDDK NIH HHS/United States
- DK090570/DK/NIDDK NIH HHS/United States
- U24 DK059637/DK/NIDDK NIH HHS/United States
- R01 DK090570/DK/NIDDK NIH HHS/United States
- P60 DK020593/DK/NIDDK NIH HHS/United States
- R01 DK068471/DK/NIDDK NIH HHS/United States
- P30 DK058404/DK/NIDDK NIH HHS/United States
- R21 DK068854/DK/NIDDK NIH HHS/United States
- DK038325/DK/NIDDK NIH HHS/United States
- DK050203/DK/NIDDK NIH HHS/United States
- U01 DK089572/DK/NIDDK NIH HHS/United States
- I01 BX000666/BX/BLRD VA/United States
- P30 DK020593/DK/NIDDK NIH HHS/United States
- P30 CA068485/CA/NCI NIH HHS/United States
- DK72473/DK/NIDDK NIH HHS/United States
- R01 DK050203/DK/NIDDK NIH HHS/United States
- DK68854/DK/NIDDK NIH HHS/United States
- DK089538/DK/NIDDK NIH HHS/United States
- U01 DK089538/DK/NIDDK NIH HHS/United States
- R21 DK066636/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous